Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models

STAR Protoc. 2024 Sep 20;5(3):103274. doi: 10.1016/j.xpro.2024.103274. Epub 2024 Aug 21.

Abstract

Three-dimensional (3D) ex vivo cultures allow the study of cancer progression and drug resistance mechanisms. Here, we present a protocol for measuring on-target drug sensitivity in a scaffold-free 3D culture system through quantification of apoptotic tumor cells. We provide detailed steps for sample processing, immunofluorescence staining, semi-high-throughput confocal imaging, and imaged-based quantification of 3D cultures. This protocol is versatile and can be applied in principle to any patient-derived material.

Keywords: Cancer; Cell culture; Single Cell.

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Cell Culture Techniques, Three Dimensional / methods
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Drug Screening Assays, Antitumor / methods
  • Female
  • Humans
  • Ovarian Neoplasms* / drug therapy
  • Ovarian Neoplasms* / pathology
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents